Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc.

Biotechnology

US, Chicago [HQ]

Summary
IR
Fin. Reports
Financials
Leadership & Strategy
Possible Catalysts

Board & Officers
Business Intelligence
Employee Voice
Mergers and Acquisitions
Qualified Risks
ESG Scores [Soon]

Strategy & Leadership

Mergers & Acquisitions Beta

M&As

CDIO M&As
Biotechnology M&A

M&A Deals · Breakdown

Cardio Diagnostics Holdings, Inc. has no acquisition track records yet.

M&A Deals · History

Cardio Diagnostics Holdings, Inc. has no acquisition track records yet.